|
|
Pfizer, Inc. is wereldwijd het grootste farmaceutische concern. De omzet per productfamilie wordt als volgt onderverdeeld:
- biofarmaceutica (76,2%);
- generieke medicijnen (19,8%; Upjohn);
- OTC-producten (4,1%).
Eind 2019 beschikte het concern over 49 productiesites gevestigd in de wereld.
De geografische verdeling van de omzet is als volgt: Verenigde Staten (46,1%), Europa (16,8%) en andere (37,1%).
Aantal werknemers : 78 500 mensen.
|
|
|
| 2020 | | USD (in miljoenen) | % | | Oncology | 10 867 | 25.9% | | Internal Medicine | 9 003 | 21.5% | | Hospital | 7 961 | 19% | | Vaccines | 6 575 | 15.7% | | Inflammation & Immunology | 4 567 | 10.9% | | Rare Disease | 2 936 | 7% |
|
|
|
| 2019 | 2020 | Delta | | USD (in miljoenen) | % | USD (in miljoenen) | % | | United States | 23 852 | 46.1% | 21 712 | 51.8% | -8.97% | | Developed Europe | 8 701 | 16.8% | 7 788 | 18.6% | -10.49% | | Emerging Markets | 8 076 | 15.6% | 5 858 | 14% | -27.47% | | Japan | 4 140 | 8% | 2 514 | 6% | -39.26% | | China | 4 658 | 9% | 2 514 | 6% | -46.01% | | Developed Rest of World | 2 325 | 4.5% | 1 522 | 3.6% | -34.56% |
|
|
|
| Stemming  | Aantal | Percentage vrij verhandelbaar | Zelf controleren | Drijvend Totaal |
| Aandeel A |
1 |
9 448 693 867 |
5 595 584 817 |
59.2% |
3 851 000 000 |
40.8% |
59.2% |
|
| Aandeelhouders | |
|
| Naam | Aandelen | % | | The Vanguard Group, Inc. | 426 692 364 |
7,62% | | SSgA Funds Management, Inc. | 274 886 855 |
4,91% | | Wellington Management Co. LLP | 249 780 583 |
4,46% | | Capital Research & Management Co. (World Investors) | 230 086 394 |
4,11% | | Capital Research & Management Co. | 142 320 700 |
2,54% | | BlackRock Fund Advisors | 129 420 103 |
2,31% | | Geode Capital Management LLC | 94 148 117 |
1,68% | | Northern Trust Investments, Inc.(Investment Management) | 65 053 051 |
1,16% | | Norges Bank Investment Management | 60 296 992 |
1,08% | | State Farm Investment Management Corp. | 56 536 168 |
1,01% |
| Naam | Aandelen | % | | Gabelli Funds LLC | 2 098 896 |
0,0094% | | Caixa Econômica Federal | 419 700 |
0,0019% | | Itaú Unibanco SA | 194 440 |
0,0009% | | Safra Asset Management Ltda. | 118 100 |
0,0005% | | Bram Bradesco Asset Management S/A DTVM | 16 620 |
0,0001% | | Quatá Gestão de Recursos Ltda. | 2 600 |
0,0000% | | Infinity Asset Management Administração de Recursos Ltda. | 89 |
0,0000% |
|
|
|
| Naam | Aandelen | % | Totale waarde |
| Pfizer Limited (500680) | 29 243 042 | 63,9% | 2 067 337 731 USD | | SpringWorks Therapeutics, Inc. (SWTX) | 4 583 047 | 9,34% | 373 701 652 USD | | BioAtla, Inc. (BCAB) | 2 238 090 | 6,96% | 96 349 775 USD | | Cortexyme, Inc. (CRTX) | 2 056 377 | 6,95% | 85 072 316 USD | | Morphic Holding, Inc. (MORF) | 1 265 635 | 3,49% | 62 471 744 USD | | 4D Molecular Therapeutics, Inc. (FDMT) | 1 666 658 | 6,23% | 44 266 436 USD | | Sosei Group Corporation (4565) | 1 885 136 | 2,33% | 26 934 201 USD | | NextCure, Inc. (NXTC) | 1 970 759 | 7,14% | 15 470 458 USD | | RaQualia Pharma Inc. (4579) | 743 000 | 3,55% | 7 151 873 USD | | Mersana Therapeutics, Inc. (MRSN) | 0 | 0,0000% | |
|
|
|
|
- - International Market - DJIA / S&P 100, S&P 500, Stoxx Americas 100, Stoxx Global 200, Stoxx NorthAmerica 50, Stoxx USA 50 |
|
|
|
|
| - Bloomberg Code : |
PFIZ11B:BZ |
| - Reuters Code : |
|
| - Datastream code : |
|
|
|
|
Pfizer, Inc. 235 Street East 42nd NY 10017 New York City, New York Telefoon : +1 212 573 2323 Fax : +1 212 573 7851 Internet : http://www.pfizer.com |
|
|
|
BioNTech spekt omzet met coronavaccin |
Sector Farmaceutische producten - Andere
| | Verschil t.o.v. 1 jan (%) | Marktkapitalisatie (M$) |
 |
 | PFIZER, INC. | 5.43% | 220 997 |
Verbindingen : Pfizer, Inc. |
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (België)
